Shanghai Yizhong Pharmaceutical Co Ltd (688091) - Total Liabilities

Latest as of September 2025: CN¥82.76 Million CNY ≈ $12.11 Million USD

Based on the latest financial reports, Shanghai Yizhong Pharmaceutical Co Ltd (688091) has total liabilities worth CN¥82.76 Million CNY (≈ $12.11 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Shanghai Yizhong Pharmaceutical Co Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how Shanghai Yizhong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 688091 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Shanghai Yizhong Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Shanghai Yizhong Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Everi Holdings Inc NYSE:EVRI	USA	$1.94 Billion
Qingdao Haier Biomedical Co Ltd SHG:688139	China	CN¥1.15 Billion
Jiangsu Bojun Industrial Technology Co. Ltd SHE:300926	China	CN¥4.96 Billion
Zhejiang Chunhui Intelligent Control Co. Ltd. SHE:300943	China	CN¥248.56 Million
CSG Holding Co Ltd SHE:000012	China	CN¥18.25 Billion
Treehouse Foods Inc NYSE:THS	USA	$2.51 Billion
Biotage AB ST:BIOT	Sweden	Skr862.00 Million
Grupo Televisa S.A.B. F:TLV	Germany	€122.08 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Shanghai Yizhong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Shanghai Yizhong Pharmaceutical Co Ltd stock valuation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	8.67	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Shanghai Yizhong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Shanghai Yizhong Pharmaceutical Co Ltd (2017–2024)

The table below shows the annual total liabilities of Shanghai Yizhong Pharmaceutical Co Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥42.97 Million ≈ $6.29 Million	-60.40%
2023-12-31	CN¥108.52 Million ≈ $15.88 Million	+206.43%
2022-12-31	CN¥35.42 Million ≈ $5.18 Million	+41.54%
2021-12-31	CN¥25.02 Million ≈ $3.66 Million	+63.50%
2020-12-31	CN¥15.30 Million ≈ $2.24 Million	+24.79%
2019-12-31	CN¥12.26 Million ≈ $1.79 Million	-28.49%
2018-12-31	CN¥17.15 Million ≈ $2.51 Million	+6.02%
2017-12-31	CN¥16.17 Million ≈ $2.37 Million	--

About Shanghai Yizhong Pharmaceutical Co Ltd

SHG:688091 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.23 Billion

CN¥8.44 Billion CNY

Market Cap Rank

#8162 Global

#1967 in China

Share Price

CN¥40.81

Change (1 day)

+3.84%

52-Week Range

CN¥39.30 - CN¥81.75

All Time High

CN¥95.97